| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 28, 2026 | Quarterly report | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 28, 2026 | Quarterly report | ASX |
|---|
| Medicare Billing Code Secured for NextLevel Speech Devices | Aug 26, 2026 | Operations update | ASX |
|---|
| NeuroStrip secures MHRA registration | Aug 24, 2026 | Operations update | ASX |
|---|
| US FDA Registration and Device Listing for NeuroStrip | Aug 3, 2026 | Operations update | ASX |
|---|
| Commercial momentum builds across both platform pillars | Jul 30, 2026 | Operations update | ASX |
|---|
| Completion of Placement | Jun 24, 2026 | Financing | ASX |
|---|
| Pause in Trading | Jun 23, 2026 | Trading halt or suspension | ASX |
|---|
| Commercial Momentum Presentation | Jun 3, 2026 | Operations update | ASX |
|---|
| German Statutory Reimbursement Listing for NeuroNode | Mar 3, 2026 | Operations update | ASX |
|---|
| Joint venture with NextLevel Assistive Technology | Feb 25, 2026 | Acquisition or disposal | ASX |
|---|
| Half Yearly Report and Accounts | Feb 25, 2026 | Interim report | ASX |
|---|
| PRC-Saltillo - Distribution Agreement | Jan 28, 2026 | Acquisition or disposal | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Jan 27, 2026 | Quarterly report | ASX |
|---|
| Tobii Dynavox - Distribution Partnership | Jan 26, 2026 | Operations update | ASX |
|---|
| Acquisition of Full Ownership of Neuro Elite Athletics | Dec 2, 2025 | Acquisition or disposal | ASX |
|---|
| Placement to Raise $3.25 million | Dec 1, 2025 | Financing | ASX |
|---|
| Control Bionics Integrates with Apple BCI Protocol | Nov 11, 2025 | Operations update | ASX |
|---|
| Rights Issue Offer Booklet | Sep 3, 2025 | Offer document | ASX |
|---|
| Preliminary Final Report | Aug 28, 2025 | Results | ASX |
|---|
| Non-Renounceable Rights Issue | Aug 27, 2025 | Financing | ASX |
|---|
| FY25 Trading Update and NeuroStrip Progress | Jun 12, 2025 | Other filings | ASX |
|---|
| Private Placement | Feb 24, 2025 | Financing | ASX |
|---|
| First Half FY25 Business Update | Dec 16, 2024 | Results | ASX |
|---|
| Expansion into US Sports and Japanese Rehab Markets | Dec 15, 2024 | Operations update | ASX |
|---|
| Coffee Microcaps Meeting Presentation | Nov 7, 2024 | Other filings | ASX |
|---|
| SIGNIFICANT INCREASE IN REVENUE FROM FASTER NDIS APPROVALS | Oct 3, 2024 | Results | ASX |
|---|
| ADDENDUM TO NOTICE OF 2024 AGM | Sep 27, 2024 | Other filings | ASX |
|---|
| Placement | Sep 23, 2024 | Financing | ASX |
|---|
| NON-RENOUNCEABLE RIGHTS ISSUE OFFER AND PRIVATE PLACEMENT AD | Sep 20, 2024 | Financing | ASX |
|---|
| Non-Renounceable Issue | Sep 19, 2024 | Other filings | ASX |
|---|
| Investor Presentation | Sep 19, 2024 | Other filings | ASX |
|---|
| Trading Halt | Sep 19, 2024 | Trading halt or suspension | ASX |
|---|
| Exclusive UK and Ireland Distribution Agreement | Sep 8, 2024 | Acquisition or disposal | ASX |
|---|
| New US Insurance Code Approved | Aug 18, 2024 | Operations update | ASX |
|---|
| Share placement - North Star Impact Fund to invest | Jul 31, 2024 | Financing | ASX |
|---|
| TGA Approval Granted for DROVE Autonomous Wheelchair Module | Jun 19, 2024 | Operations update | ASX |
|---|
| Control Bionics completes successful $1.04m placement | May 15, 2024 | Financing | ASX |
|---|
| Autonomous Wheelchair Project - US Research Award | Jan 23, 2024 | Operations update | ASX |
|---|
| Completion of Placement of Rights Issue Shortfall | Jan 18, 2024 | Financing | ASX |
|---|
| Rights Issue Results | Nov 29, 2023 | Financing | ASX |
|---|
| Pro rata rights issue | Oct 29, 2023 | Financing | ASX |
|---|
| Control Bionics Unveils the NeuroStrip | Oct 12, 2023 | Other filings | ASX |
|---|
| Extension to Rights Issue Closing Date | Jun 13, 2023 | Financing | ASX |
|---|
| DROVE - Presentation at Deakin University | Apr 18, 2023 | Other filings | ASX |
|---|
| DROVE - Press Release | Apr 18, 2023 | Other filings | ASX |
|---|
| DROVE - Worlds First Wheelchair Self-drive Controller | Apr 17, 2023 | Other filings | ASX |
|---|
| Appointment of CEO | Jan 19, 2023 | Management or board change | ASX |
|---|
| CEO Resignation | Sep 14, 2022 | Other filings | ASX |
|---|
| Appendix 4E | Aug 24, 2022 | Results | ASX |
|---|
| Monthly Activities/Appendix 4C Cash Flow Report | Apr 27, 2022 | Quarterly report | ASX |
|---|
| CBL Enters Japanese Market with NeuroNode Technology | Apr 11, 2022 | Other filings | ASX |
|---|
| Morgans Investment Conference Presentation | Nov 24, 2021 | Other filings | ASX |
|---|
| Introduction of rental alternative to Australian market | Oct 19, 2021 | Other filings | ASX |
|---|
| Appendix 4C - Quarterly | Apr 28, 2021 | Quarterly report | ASX |
|---|
| Release of half year results and webinar | Feb 22, 2021 | Interim report | ASX |
|---|
| Appendix 4C - quarterly | Jan 20, 2021 | Quarterly report | ASX |
|---|
| Voluntary Administration Sale of PFP Business | Jul 4, 2018 | Other filings | ASX |
|---|
| CBL Corporation enters Voluntary Administration | Feb 25, 2018 | Other filings | ASX |
|---|
| CBI Direction | Feb 19, 2018 | Other filings | ASX |
|---|
| CBL updates the market on AM Best credit rating downgrade | Feb 7, 2018 | Other filings | ASX |
|---|
| Suspension from Official Quotation | Feb 5, 2018 | Trading halt or suspension | ASX |
|---|
| CBL UPDATES THE MARKET ON FY17 RESULTS EXPECTATIONS | Feb 4, 2018 | Other filings | ASX |
|---|
| CBL subsidiary in Luxembourg fined EUR5,000 being appealed | Jan 2, 2018 | Other filings | ASX |
|---|
| Results Announcement - NZX Appendix 1 | Aug 23, 2017 | Other filings | ASX |
|---|
| STRONG GROWTH BUT PROFIT IMPACTED BY STRENGTHENING RESERVES | Aug 17, 2017 | Operations update | ASX |
|---|
| CBL ANNOUNCES IRISH ACQUISITION | Jul 10, 2017 | Acquisition or disposal | ASX |
|---|
| CBL INSURANCE RETAINS RATING OF A- | Jun 12, 2017 | Other filings | ASX |
|---|
| CBL Share Sell-Down To Increase Share Market Liquidity | Apr 4, 2017 | Other filings | ASX |
|---|
| CBL ANNOUNCES CONDITIONAL AGREEMENT TO BUY US INSURER | Mar 24, 2017 | Other filings | ASX |
|---|
| CBL Supplementary Information for the 2016 Annual Result | Feb 28, 2017 | Other filings | ASX |
|---|
| CBL Results Presentation | Feb 23, 2017 | Other filings | ASX |
|---|
| Focused and consistent strategy sees CBL beat forecasts | Feb 23, 2017 | Other filings | ASX |
|---|
| CBL CORPORATION CLOSES NZ$150M STRATEGIC ACQUISITION | Jan 5, 2017 | Acquisition or disposal | ASX |
|---|
| CBL obtains regulatory approval for SFS Acquisition | Oct 10, 2016 | Acquisition or disposal | ASX |
|---|
| CBL Corporation completes Placement | Sep 29, 2016 | Financing | ASX |
|---|
| CBL Corporation announces equity raising | Sep 28, 2016 | Other filings | ASX |
|---|
| CBL Corporation Limited 2016 Half Year Results | Aug 25, 2016 | Interim report | ASX |
|---|
| CBL Corporation plans acquisition of SFS | Jun 22, 2016 | Acquisition or disposal | ASX |
|---|
| CBL announces maiden dividend. | Mar 30, 2016 | Dividend | ASX |
|---|
| Full Year Statutory Accounts | Feb 28, 2016 | Annual report | ASX |
|---|
| CBL ANNOUNCES NEW LICENCES IN MEXICO | Feb 19, 2016 | Other filings | ASX |
|---|
| CBL delivers clear strategy for Assetinsure Pty Ltd | Feb 11, 2016 | Other filings | ASX |
|---|
| CBL exercises option to acquire shares from shareholder | Feb 10, 2016 | Acquisition or disposal | ASX |
|---|